MYELOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSU S ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODIES

Citation
I. Feki et al., MYELOPATHY IN SYSTEMIC LUPUS-ERYTHEMATOSU S ASSOCIATED WITH ANTIPHOSPHOLIPID ANTIBODIES, Revue neurologique, 153(2), 1997, pp. 138-140
Citations number
10
Categorie Soggetti
Clinical Neurology
Journal title
ISSN journal
00353787
Volume
153
Issue
2
Year of publication
1997
Pages
138 - 140
Database
ISI
SICI code
0035-3787(1997)153:2<138:MISLSA>2.0.ZU;2-N
Abstract
Central nervous system involvement in systemic lupus erythematosus (SL E) is frequent and severe, however, myelopathy is rarely reported (0.8 p. 100 of SLE cases). We describe two SLE-young women. They were 21 a nd 37 year old, presented with acute paraplegia. CSF study showed pleo cytosis and moderately elevated protein. Antinuclear, anti-DNA and ant icardiolipin were positive. High dose steroids therapy induced marked improvement The pathogenesis of myelopathy in SLE remains unclear. Ant i-phospholipid antibodies may cause thrombosis and ischemic myelopathy . However, auto-antibodies directed against central nervous system con stituents may be involved.